There are thousands of wellness apps in the app store. When we asked Naser Partovi what sets Wellaho apart from the crowd, allowing it to help individuals manage chronic conditions, he had a three-part answer:
1. It’s a prescribable app, connecting patient and clinician, sending individually-configured alerts to the clinician as appropriate.
2. It’s been validated through numerous clinical trials.
3. It’s personalized medicine — the app is configured to reflect an individual’s history and experience (e.g., diagnosed with diabetes 10 years ago, not taking insulin).
For conditions subject to the preventable readmission rule, Wellaho customers are the hospitals that would be on the hook financially for a readmission: the hospital is the party most interested in preventing the readmission because it will not be able to bill for the readmission if it is for a condition on the Medicare list (currently COPD, pneumonia and acute myocardial infarction). For other conditions, the customer is the insurance company covering an individual with a chronic condition.
Join Naser Partovi at Diabetes Innovation 2013, and hear more about Wellaho — and a new soon-to-be unveiled product as well.
Have a listen to our interview (press play); read the transcript after the jump.